In contrast, treatment category was not significantly associated with survival status ( p = 0.074), although a numerical trend toward improved outcomes was observed in patients receiving standard therapy with or without immunotherapy.
← all excerpts
Pseudotime-Based derivation of a PET-Based metabolic progression index for prognostic stratification in Extensive-Stage SCLC.
1
—
—